Moderate FAS requires which approach?

Moderate FAS requires which approach?

• A. multimodal protocols
• B. add an opioid to the alpha-2 agonist
• C. Both multimodal protocols and addition of an opioid to the alpha-2 agonist
• D. No changes

Answer: (C)

Moderate FAS requires a multimodal approach that combines different ways to control pain, anxiety, and stress during procedures. Using multiple drugs that act through different mechanisms allows you to achieve adequate anxiolysis and analgesia with lower doses of each agent, reducing side effects and improving safety. Alpha-2 agonists provide sedation and some analgesia, but relying on them alone can be insufficient for moderate procedures and may cause cardiovascular or respiratory depression at higher doses. Adding an opioid to the alpha-2 agonist enhances analgesia and can help achieve a deeper, steadier level of comfort without needing to push the alpha-2 dose higher. This opioid addition improves overall sedation quality and pain control, which is especially important for moderate FAS where stress and nociception need to be well-managed. In practice, a multimodal plan might pair an alpha-2 agonist with an opioid and include other modalities such as nonsteroidal anti-inflammatory drugs, local anesthetics, or other analgesics as appropriate. This combination provides balanced sedation and analgesia, minimizes pain and stress, and reduces the risk of adverse effects compared with a single-drug approach.

Moderate FAS requires a multimodal approach that combines different ways to control pain, anxiety, and stress during procedures. Using multiple drugs that act through different mechanisms allows you to achieve adequate anxiolysis and analgesia with lower doses of each agent, reducing side effects and improving safety.

Alpha-2 agonists provide sedation and some analgesia, but relying on them alone can be insufficient for moderate procedures and may cause cardiovascular or respiratory depression at higher doses. Adding an opioid to the alpha-2 agonist enhances analgesia and can help achieve a deeper, steadier level of comfort without needing to push the alpha-2 dose higher. This opioid addition improves overall sedation quality and pain control, which is especially important for moderate FAS where stress and nociception need to be well-managed.

In practice, a multimodal plan might pair an alpha-2 agonist with an opioid and include other modalities such as nonsteroidal anti-inflammatory drugs, local anesthetics, or other analgesics as appropriate. This combination provides balanced sedation and analgesia, minimizes pain and stress, and reduces the risk of adverse effects compared with a single-drug approach.